Hepatitis A

Hepatitis A is a liver disease caused by the hepatitis A virus (HAV).

HAV is usually spread from person to person by putting something in the mouth that has been contaminated with the stool of a person with hepatitis A.

Vaccination: Is given as one injection. A second dose of this vaccine is required after 6-12 months to provide immunity for approximately 20 years. ‘Booster?injections are needed approximately every 20 years to provide continued immunity.

Protection: After one dose nearly one year. A second dose of this vaccine after 6-12 months provides immunity for approximately 20 years.

Side effects includes:

Redness around injection site
Hardening of skin around injection site
Weakness
Headache
Loss of appetite
Fever

hepa Resource:

[Henry Toussaint and Louis Pasteur. Rivalry over a vaccine].

Hist Sci Med

Factors limiting traditional household duck production in Bangladesh.

Trop Anim Health Prod

Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine.

Clin Vaccine Immunol

Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.

Proc Natl Acad Sci U S A

Cholera - recommendations for prevention in travellers.

Aust Fam Physician

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

Vaccine

Cholera vaccines: WHO position paper.

Wkly Epidemiol Rec

Influence of maternal gestational treatment with mycobacterial antigens on postnatal immunity in an experimental murine model.

PLoS One

Development of antitumor immunity by oral vaccination with tumor antigen and cholera toxin.

J Nihon Med Sch

Determining the activity of mucosal adjuvants.

Methods Mol Biol

[Role of cholera toxin-induced apoptosis in alteration of macrophages in mice].

Zh Mikrobiol Epidemiol Immunobiol

Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments.

Jpn J Infect Dis

Experimental iron-inactivated Pasteurella multocida A: 1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera.

Vaccine

Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

J Virol

Intranasal immunization with Leish-111f induces IFN-gamma production and protects mice from Leishmania major infection.

Vaccine

Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection.

Vaccine

Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection.

J Biotechnol

Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

J Immunol

Primary porcine CD11R1+ antigen-presenting cells isolated from small intestinal mucosa mature but lose their T cell stimulatory function in response to cholera toxin treatment.

Vet Immunol Immunopathol

Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.

FEMS Immunol Med Microbiol

First

Last

Jump:

To top Back to list of vaccination • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.